Search Result "enasidenib"
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 14 Year: 2018 Page: 1936-1951
Author(s): Raghav Dogra,Rohit Bhatia,Ravi Shankar,Parveen Bansal,Ravindra K. Rawal
Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 505-524
Author(s): Horrick Sharma
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 490-500
Author(s): Justin S. Becker,Amir T. Fathi
Isocitrate Dehydrogenase 2 Inhibitors for the Treatment of Hematologic Malignancies: Advances and Future Opportunities
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 9 Year: 2021 Page: 1113-1122
Author(s): Feng Huang,Tian Tian,Yizhe Wu,Jinxin Che,Haiyan Yang,Xiaowu Dong
Targeting Cancer Metabolism as a Novel Anticancer Strategy
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 429-431
Author(s): Horrick Sharma
Novel Mitochondria-targeted Drugs for Cancer Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 7 Year: 2021 Page: 816-832
Author(s): Jindriska Leischner Fialova,Martina Raudenska,Milan Jakubek,Zdenek Kejik,Pavel Martasek,Petr Babula,Adam Matkowski,Petr Filipensky,Michal Masarik
1,3,5-Triazine-azole Hybrids and their Anticancer Activity
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 16 Year: 2020 Page: 1481-1492
Author(s): Hua Guo,Quan-Ping Diao
Recent Advances on PKM2 Inhibitors and Activators in CancerApplications
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2955-2973
Author(s):
Epigenetics Mechanism and Therapeutic Potential of Approved Epi-drugsin Pulmonary Hypertension Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 18 Year: 2023 Page: 1715-1726
Author(s):
The Regulatory Mechanisms and Clinical Significance of Lnc SNHG4 inCancer
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 44 Year: 2022 Page: 3563-3571
Author(s): Abdol Azim Nejatizadeh